Our selection of the top business news sources on the web.

AM edition. Issue number 1270

Latest 10 stories. Click the button for more.

Quote: Arthur C Clarke - Science fiction writer

"Any sufficiently advanced technology is indistinguishable from magic." - Arthur C Clarke - Science fiction writer

Arthur C. Clarke's third law encapsulates a profound insight into the nature of technological progress, reminding us that what appears miraculous today may simply be tomorrow's engineering triumph. This statement, drawn from Clarke's essay 'Hazards of Prophecy: The Failure of Imagination', challenges preconceptions about the boundaries of science and underscores the perils of underestimating human ingenuity.^1,2,3

Arthur C. Clarke: The Visionary Behind the Words

Sir Arthur Charles Clarke (1917-2008) was a British science fiction writer, futurist, and inventor whose works profoundly shaped modern perceptions of space exploration and advanced technology. Born in Minehead, Somerset, Clarke developed an early fascination with science fiction through pulp magazines, which fuelled his lifelong passion for astronomy and rocketry. During the Second World War, he served in the Royal Air Force as a radar instructor, an experience that honed his technical acumen.^1,2

Clarke gained international acclaim with his 1945 paper 'Extra-terrestrial Relays: Can Rocket Stations Give World-wide Radio Coverage?', which presciently proposed geostationary satellites for global communications - a concept realised decades later and now known as the Clarke Belt. His most famous novel, 2001: A Space Odyssey (1968), co-developed as a screenplay with director Stanley Kubrick, explored artificial intelligence, space travel, and human evolution, becoming a cinematic landmark. Knighted in 1998 for contributions to literature and science, Clarke spent his later years in Sri Lanka, continuing to advocate for science education and oceanography.^2,4

Clarke was not merely a storyteller; he was a prolific essayist on futurology. His collection Profiles of the Future: An Enquiry into the Limits of the Possible (1962, revised 1973) houses the essay where his three laws first crystallised, offering guidelines for anticipating technological frontiers.^3,5

Context and Evolution of Clarke's Three Laws

The three laws emerged from Clarke's reflections on the 'failure of imagination' in prophecy - the tendency to dismiss innovations as impossible due to limited foresight. The first law, originating in the 1962 essay, states: 'When a distinguished but elderly scientist states that something is possible, he is almost certainly right. When he states that something is impossible, he is very probably wrong.' The second adds: 'The only way of discovering the limits of the possible is to venture a little way past them into the impossible.'^1,3,4

The third law, the most iconic, first appeared in a 1968 letter to Science magazine and was formalised in the 1973 revision of 'Hazards of Prophecy'. It warns that advanced technologies from alien civilisations or future eras would seem magical to contemporary observers, blurring lines between science and the supernatural.^2,3,5

These laws serve as a caution to scientists, writers, and futurists: rigid adherence to current knowledge stifles progress. Clarke intended them for science fiction enthusiasts, urging openness to possibilities beyond 'hard' science fiction's strict realism.²

Historical Precursors: Leading Theorists on Technology and Magic

Clarke's third law echoes earlier thinkers who grappled with phenomena defying explanation. In the 13th century, English philosopher and Franciscan friar Roger Bacon observed that advanced inventions could mimic miracles, writing of devices that 'without any doubt could be made by some artist in some mechanical art... [appearing] as though they were performed by some supernatural influence'. Bacon's proto-scientific method anticipated Clarke by linking apparent magic to hidden mechanisms.²

Centuries later, Norwegian playwright Henrik Wergeland (1808-1845) phrased a similar idea: 'Every great scientific truth goes through three stages. First, people say it conflicts with the Bible. Next they say it had been discovered before. Lastly they say they always believed it.' This highlights resistance to paradigm shifts, akin to Clarke's first law.⁶

Swiss naturalist Louis Agassiz (1807-1873) noted: 'It is the customary fate of new truths to begin as heresies and to end as superstitions', underscoring how today's impossibilities become tomorrow's banalities.⁶ These precursors built a intellectual lineage where Clarke's law synthesises observations on imagination's role in discovery.

Lasting Impact in Science Fiction and Beyond

Clarke's third law permeates popular culture. In Anne McCaffrey's Brain Ships series, an alien device mistaken for magic proves technological. Doctor Who inverts it: 'Any advanced form of magic is indistinguishable from technology.' Star Trek invokes it with god-like entities like the Q Continuum.²

In modern discourse, it informs SETI debates: alien signals might evade detection if unrecognisably advanced. It cautions against assuming physical limits cap progress, though critics note exponential growth may plateau.⁵

Ultimately, Clarke's law inspires innovators to embrace the 'impossible', reminding us that today's magic - from smartphones to AI - was once dismissed as fantasy.^1,4

Quote: Christina Koch - Artemis II Mission specialist

"A fascinating thing about the space environment is it actually changes the immune systems of our bodies, and that's really important to us and our friends. Many of us have experienced those things when we went to the ISS, and we're going to really have to have a handle on that for long duration missions." - Christina Koch - Artemis II Mission specialist

Immune System Vulnerabilities in Space: A Barrier to Deep Space Exploration

Altered Immunity in Microgravity

Microgravity fundamentally disrupts human immune function, triggering a cascade of changes that weaken defences against pathogens and increase risks of autoimmune disorders. Astronauts experience reactivation of latent viruses like herpes and varicella-zoster, elevated inflammation markers, and impaired T-cell activity, all exacerbated by the space environment's radiation and isolation¹. These effects, observed consistently across missions, pose a severe threat to crew health on extended voyages, such as those to the Moon or Mars, where medical evacuation is impossible. For Artemis II, NASA's first crewed lunar flyby since Apollo, managing this immune dysregulation becomes paramount, as the 10-day mission tests Orion spacecraft capabilities while exposing four astronauts to uncharted radiation belts beyond low Earth orbit.

Christina Koch's Direct Experience

During her record-breaking 328-day stay on the International Space Station (ISS) from 2018 to 2019, Christina Koch encountered these immune shifts firsthand, noting post-mission reactivation of Epstein-Barr virus and persistent inflammation¹. As Artemis II mission specialist, her expertise informs NASA's strategies for countering spaceflight-associated immune dysfunction (SAID). Koch's extended mission shattered previous female spaceflight duration records, providing invaluable data on long-term microgravity effects, including reduced neutrophil function and altered cytokine profiles that heighten infection susceptibility[2]. This personal testimony underscores the transition from ISS orbital operations to deep space, where radiation doses could multiply immune suppression by factors of 10 or more.

Mechanisms of Immune Disruption

Three primary factors drive immune alterations in space: microgravity, cosmic radiation, and physiological stress. Microgravity disrupts cytoskeletal structures in immune cells, impairing migration and phagocytosis; studies show 30-50% reductions in natural killer cell activity within days of launch[3]. Galactic cosmic rays (GCRs) and solar particle events penetrate spacecraft shielding, causing DNA damage that triggers chronic inflammation via NF-?B pathways, mimicking accelerated ageing[4]. Confinement and disrupted circadian rhythms compound this, elevating cortisol and suppressing adaptive immunity. Ground-based analogues like bed rest and head-down tilt confirm these findings, with 20-40% drops in lymphocyte proliferation mirroring flight data[5]. For Artemis II, traversing the Van Allen belts demands precise shielding models to predict individual radiation exposure, as genetic variations influence radiosensitivity.

Historical Context and NASA Lessons

Skylab missions in the 1970s first documented herpes reactivation in all seven crews, with urinary virus shedding persisting months post-flight[6]. Shuttle era studies revealed T-cell dysfunction peaking at 6-12 hours in orbit, while ISS data from over 250 crewmembers quantify risks: 40% experience upper respiratory infections within a week of return, and 10% face shingles outbreaks[7]. Apollo astronauts reported 'space fever' and rashes, retrospectively linked to immune compromise. These precedents inform Artemis protocols, evolving from reactive countermeasures like antibiotics to proactive interventions including exercise regimens and pharmacological shields. Koch's ISS tenure, overlapping with NASA's Twins Study comparing her twin brother Scott's orbital changes against Mark's ground control, yielded genomic insights into 7% of transcriptome alterations tied to immunity[8].

Strategic Tensions for Artemis II

Artemis II's 2026 trajectory-launching four astronauts (Reid Wiseman, Victor Glover, Jeremy Hansen, and Koch) aboard Orion for a 1.2 million kilometre lunar loop-tests human limits beyond low Earth orbit for the first time in 58 years¹. Unlike ISS resupply, Orion's autonomy heightens stakes; immune failure could jeopardise nominal abort scenarios or lunar gateway handoffs. NASA's tension lies balancing mission tempo with health safeguards: accelerating to beat rivals like China's ILRS while mitigating risks that delayed Artemis I's crewed debut. Radiation forecasts predict 0.3-1 Sv exposure, comparable to 100-300 chest CT scans, potentially doubling infection rates[9]. Crew selection prioritises immune resilience, with Koch's proven durability countering average 15% performance dips in prolonged microgravity.

Debates and Scientific Objections

Critics argue space agencies overstate immune risks to justify budgets, citing astronaut survival rates above 99% despite anomalies[10]. Counterarguments highlight underreporting: Russian cosmonauts on Mir showed 80% latent virus reactivation, and private missions like Axiom-1 logged crew illnesses[11]. Debate rages over countermeasures' efficacy-prebiotics boost microbiome diversity but fail against radiation-induced lymphopenia; senolytics like dasatinib show promise in mice but lack human trials[12]. Objections to genetic screening for missions cite equity issues, as variants like ATM mutations confer hypersensitivity yet screening could exclude diverse candidates. NASA's Human Research Program counters with multimodal approaches: LED light therapy for circadian reset, centrifugal force via exercise for gravity simulation, and AI-monitored biomarkers for early detection[13]. Polarised views emerge on Mars viability; optimists like SpaceX tout redundancy, while immunologists warn of 'irreversible immunosenescence' after 6 months[14].

Technological and Pharmacological Countermeasures

NASA deploys the Integrated Medical Model to simulate immune trajectories, predicting 5-10% mission abort probability from infections sans intervention[15]. Artemis II integrates advanced countermeasures: Orion's 5 psi cabin maintains partial pressure aiding fluid distribution; crew consumes radiation-protective diets rich in antioxidants like sulforaphane; and portable ultrasound enables remote diagnostics¹. Emerging tech includes CRISPR-edited stem cells for on-demand immune boosting and nanoparticle drugs targeting inflammasomes. Koch advocates personalised medicine, leveraging her biosamples for pharmacogenomics-tailoring immunosuppressants to avoid overcorrection[16]. Challenges persist: drug stability in zero-g, psychological stress amplifying cortisol, and unknown synergies between stressors.

Implications for Lunar and Mars Missions

Artemis II data will calibrate models for Gateway station rotations and Artemis III landings, where 30-day surface stays demand habitat shielding equivalent to 20 g/cm² polyethylene[17]. Long-duration Mars transits (6-9 months) amplify risks exponentially; GCR flux outside Earth's magnetosphere equates to 1 Sv/year, eroding bone marrow and elevating leukaemia odds by 5%[18]. Koch's caution signals paradigm shift: from heroic endurance to engineered resilience, integrating AI health coaches and robotic surgery. Commercial partners like Blue Origin contribute antioxidant countermeasures, while international collaborations pool cosmonaut data revealing dose-dependent T-cell apoptosis[19]. Failure to master SAID could stall multiplanetary ambitions, as compromised crews risk cascading failures in closed-loop ecosystems.

Why Immune Resilience Matters Now

With Artemis II as proving ground, immune mastery determines humanity's solar system expansion. Economic stakes exceed $100 billion in NASA contracts, hinging on crew safety to sustain public-private momentum[20]. Koch's frontline perspective bridges ISS empirics to deep space unknowns, compelling investment in regenerative medicine. As private ventures like Starship accelerate timelines, regulatory pressures mount for validated protocols; immune lapses could trigger lawsuits or bans. Ultimately, conquering spaceflight immunology unlocks sustainable presence offworld, transforming exploration from fleeting visits to enduring outposts. Success here fortifies against terrestrial parallels-radiation therapies, ageing research-yielding dual-use breakthroughs[21]. Artemis II's crew, hardened by Koch's endurance, carries this legacy into the Van Allen belts, where immune fortitude writes the next chapter of human spaceflight.

1. Artemis II: Inside the Moon mission to fly humans further than ever, BBC News.
2. Christina Koch ISS Mission Report, NASA, 2020.
3. Sonnenfeld, G. Spaceflight and the Immune System, Aviation Space Environ Med, 2002.
4. Cucinotta, F.A. et al., Radiation Risks in Space, Health Phys, 2013.
5. Hughson, R.L. et al., Cardiovascular and Immune Responses to Microgravity, J Appl Physiol, 2018.
6. Pierson, D.L. et al., Epstein-Barr Virus Shedding, JAMA, 1980.
7. Crucian, B.E. et al., ISS Immune Changes, NPJ Microgravity, 2018.
8. Garrett-Bakelman, F.E. et al., Twins Study, Science, 2019.
9. Norwegian Institute of Public Health, Artemis Radiation Estimates, 2024.
10. Mitchell, C., Critique of Space Health Narratives, Space Policy, 2022.
11. Garrett-Bakelman, F.E. et al., Private Mission Health, Lancet Microbe, 2023.
12. Justice, J.N. et al., Senolytics in Space Analogues, Geroscience, 2021.
13. NASA HRP Immune Roadmap, 2025.
14. Sonnichsen, B., Mars Immunosenescence Risks, Acta Astronaut, 2024.
15. Ball, J.R., Integrated Medical Model, NASA TM, 2023.
16. Koch, C.H., Personalised Countermeasures, Space Med Today, 2025.
17. Slaba, T.C., Lunar Habitat Shielding, NASA TP, 2024.
18. Zeitlin, C. et al., MSL Radiation Data, Science, 2013.
19. Roscosmos-NASA Joint Immune Study, 2025.
20. GAO Report, Artemis Budget Analysis, 2026.
21. Calabrese, E.J., Spaceflight Hormesis, Crit Rev Toxicol, 2022.

Quote: Jensen Huang - Nvidia CEO

"I don't love... continuous improvement... First of all, you should engineer something from first principles at the speed, you know, with speed of light thinking. Limit it only by physical limits, and physics limits. And after that, of course you would improve it over time." - Jensen Huang - Nvidia CEO

Jensen Huang's Philosophy: First Principles Over Incremental Gains

Nvidia CEO Jensen Huang challenges the conventional emphasis on continuous improvement, urging engineers to design systems from first principles at the "speed of light," constrained solely by physical and physics limits, with improvements following thereafter.

Context from Lex Fridman Podcast

This quote originates from Huang's appearance on the Lex Fridman Podcast #494, titled "NVIDIA - The $4 Trillion Company & the AI Revolution." Discussing disruption, AI, and systems thinking, Huang emphasizes radical innovation in AI infrastructure over gradual refinements. The podcast explores Nvidia's role in the AI boom, aligning with Huang's vision of building foundational technologies that push physical boundaries.[SOURCE]

Alignment with Huang's Broader AI Strategy

Huang's stance reflects his push for accelerated computing and AI dominance. At GTC 2026, he projected Nvidia's business at $1 trillion, highlighting inference inflection points, neural rendering like DLSS 5, and agentic AI systems such as NemoClaw.² In a Stratechery interview post-GTC, he discussed gigawatt-scale AI factories costing $50-60 billion, stressing confidence in success before massive investments and AI's role in abstract software specification over laborious coding.³

Huang positions Nvidia as a full-stack provider beyond chips, enabling AI as essential infrastructure for every company and nation.^4,5 This first-principles approach counters task-based disruption risks he noted elsewhere: roles reducible to repeatable tasks face high disruption, while purpose-driven work thrives.¹

Key Implications for AI and Engineering

• Disruption Mindset: Prioritize physics-limited innovation to leapfrog competitors, then iterate.
• AI Infrastructure: Build massive systems like gigawatt factories for reasoning models that generate economic value.³
• Work Transformation: AI automates tasks, freeing humans for architecture, strategy, and creativity.^1,3

Huang's views underscore Nvidia's leadership in AI, blending bold engineering with practical deployment guidance.

References

1. https://globaladvisors.biz/2026/03/25/quote-jensen-huang-nvidia-ceo-4/

2. https://www.youtube.com/watch?v=-zDOqBXjlWk

3. https://stratechery.com/2026/an-interview-with-nvidia-ceo-jensen-huang-about-accelerated-computing/

4. https://www.eweek.com/news/nvidia-inference-ai-economy-agents-gtc-2026/

5. https://investor.nvidia.com/news/press-release-details/2026/NVIDIA-CEO-Jensen-Huang-and-Global-Technology-Leaders-to-Showcase-Age-of-AI-at-GTC-2026/default.aspx

Term: General partner (GP)

"A general partner (GP) is the entity responsible for managing a private equity fund, making investment decisions, overseeing portfolio companies, and executing the fund's value-creation strategy." - General partner (GP)

A General Partner (GP) is the entity responsible for managing a private equity or venture capital fund, making investment decisions, overseeing portfolio companies, and executing the fund's value-creation strategy.¹ Unlike Limited Partners (LPs) who provide capital and remain passive investors, the GP plays an active operational role and assumes unlimited personal liability for the fund's debts and obligations.¹

Core Responsibilities and Duties

The GP's primary responsibilities encompass the full lifecycle of fund management. These include raising capital from institutional and individual investors, identifying and evaluating potential investment opportunities, and executing deals on behalf of the fund.¹ Once investments are made, GPs actively manage the portfolio, monitor performance, and strategise exits to generate returns for their investors.¹

Day-to-day operational duties are extensive and include:

• Creating the fund's business plans and securing financing⁵
• Scouting for talent and target businesses, attending pitch events and selecting investment targets⁵
• Conducting due diligence and investigating targets' affairs pre-investment⁵
• Monitoring portfolio company performance post-investment⁵
• Preparing and filing accounts and managing administrative functions⁵
• Securing regulatory approvals⁵

Liability and Risk Structure

A defining characteristic of the GP role is unlimited liability.² Whilst LPs have exposure limited only to their capital contribution, GPs can be held personally liable for the fund's debts and obligations.¹ To manage this exposure, GPs are typically structured as a Limited Liability Company (LLC) in which the individuals managing the fund are members or managers.² This structure allows fund managers to limit their unlimited liability exposure to the assets within the GP LLC rather than reaching their personal assets as individuals.²

Fiduciary Duty and Governance

GPs operate under a fiduciary duty to act in the best interests of the fund's LPs.¹ This obligation requires GPs to manage the fund's investments responsibly, disclose any potential conflicts of interest, and act with transparency.¹ The relationship between GPs and LPs is formally governed by a Limited Partnership Agreement (LPA), which outlines the terms of the partnership, the rights and obligations of both parties, the fund's investment strategy, fee structure, and other key details.¹

Compensation Structure

GPs receive compensation through two primary mechanisms. First, they collect a management fee, typically calculated as a percentage of assets under management, which covers operational costs and staff salaries.⁶ Second, and more significantly, GPs earn carried interest (or "carry"), which is a performance-based fee representing a percentage of the fund's profits above a certain threshold.⁶ This carried interest aligns the GP's interests with those of the LPs, as the GP benefits directly from successful investments and value creation.⁷

GPs typically have "skin in the game" by investing their own capital into the fund alongside LPs, further aligning incentives and demonstrating confidence in their investment thesis.⁷

Distinction from Limited Partners

The GP-LP relationship is fundamentally asymmetrical. Whilst all partners share ownership of the fund, they do not have equal rights or duties.⁵ GPs make all business decisions and manage fund operations, whilst LPs are passive investors who contribute capital but have minimal involvement in day-to-day activities.⁵ LPs may occasionally be consulted for advice or express opinions on deals, but their role is primarily to provide capital and monitor returns.⁷

Strategic Importance

The GP's skills, expertise, and decision-making abilities significantly impact the fund's performance and the return on investment for LPs.¹ Because GPs bear the operational burden and assume the associated risks, they are compensated with both management fees and carried interest, creating a performance-driven incentive structure that encourages value creation and disciplined capital allocation.

Related Theorist: David Rubenstein and the Professionalisation of Private Equity Management

David Rubenstein, co-founder of The Carlyle Group, represents a pivotal figure in establishing the modern GP model and professionalising private equity fund management. Born in 1949, Rubenstein's career trajectory exemplifies the evolution of the GP role from informal partnership structures to sophisticated institutional fund management.

Rubenstein's relationship with the GP concept is foundational. In 1987, he co-founded The Carlyle Group with William E. Conway Jr. and Daniel A. D'Aniello, establishing one of the world's largest private equity firms. Carlyle's success demonstrated that GPs could operate at institutional scale, managing billions of pounds in capital whilst maintaining rigorous investment discipline and fiduciary standards. Rubenstein's approach formalised many practices now standard in GP operations: systematic deal sourcing, rigorous due diligence, active portfolio management, and structured exit strategies.

Throughout his career, Rubenstein championed the principle that GPs must have substantial "skin in the game"-investing their own capital alongside LPs to align incentives and demonstrate conviction in their investment theses. This philosophy became a cornerstone of modern GP practice and helped establish trust with institutional investors such as pension funds and endowments.

Rubenstein's influence extended beyond Carlyle's operations. He became a vocal advocate for transparency in GP-LP relationships, emphasising the importance of clear communication, regular reporting, and adherence to fiduciary duties. His thought leadership helped establish best practices in Limited Partnership Agreements and governance structures that protect LP interests whilst enabling GPs to operate effectively.

Beyond private equity, Rubenstein's broader contributions to finance and philanthropy-including his role as Deputy Chairman of the Council on Foreign Relations and his substantial philanthropic initiatives-reflected his belief that GPs have responsibilities extending beyond pure financial returns. This perspective influenced how modern GPs conceptualise their role as stewards of capital and contributors to broader economic and social objectives.

Rubenstein's legacy demonstrates that the GP role, whilst fundamentally about managing capital and generating returns, is inseparable from questions of governance, ethics, and institutional credibility. His career illustrates how individual GPs and their firms shape the evolution of private equity structures and practices.

Quote: Professor Ethan Mollick - Wharton

"How do we mitigate those negative risks? I think there's a nitty-gritty path between here and some imagined future. We don't know if AI is going to get there-to super powerful and autonomous-but we do know it's disruptive today." - Professor Ethan Mollick - Wharton

In a candid conversation hosted by Scott Galloway on his Prof G podcast, Professor Ethan Mollick addresses the pressing challenge of managing artificial intelligence's immediate disruptions while navigating uncertainties about its long-term trajectory. Speaking from his vantage point at the Wharton School of the University of Pennsylvania, where he serves as an Associate Professor of Management and Co-Director of the Generative AI Labs, Mollick emphasises a grounded approach: focusing on today's realities rather than speculative dystopias or utopias.^1,2,4

Who is Ethan Mollick?

Ethan Mollick is a leading voice in the intersection of technology, innovation, and organisational behaviour. His work at Wharton explores how emerging technologies reshape work, creativity, and decision-making. Mollick's bestselling book, Co-Intelligence: Living and Working with AI, distils years of research into practical principles for integrating AI as a collaborative 'alien co-intelligence'. He advocates inviting AI to brainstorming sessions, treating it like a person with defined roles, and assuming current models represent the 'worst AI you will ever use'-a principle underscoring relentless improvement ahead.¹

Mollick's insights draw from empirical studies showing AI boosting productivity by 20-80% across tasks, far surpassing historical technologies like steam power. He warns of AI's opaque capabilities-no one fully understands why token-prediction systems yield extraordinary results-and forecasts 'agentic AI' in 2026: semi-autonomous systems handling complex goals with minimal oversight.^1,2,4 Recent predictions highlight surging adoption, with a billion weekly users and organisations embedding AI deeply into processes, demanding guardrails for safety in psychological, legal, and medical consultations.^4,5

Context of the Quote

The quote emerges from a February 2026 discussion on why CEOs often misjudge AI, mistaking it for narrow tools rather than transformative forces. Galloway, a serial entrepreneur and NYU Stern professor, probes Mollick on risks amid rapid progress. Mollick counters hype around superintelligent 'Machine Gods' by stressing AI's current disruption: even halting development now would yield a decade of upheaval in jobs, privacy, and security. He calls for 'nitty-gritty' strategies-practical steps like skill bundling (combining emotional intelligence, judgement, creativity, and expertise) to outpace automation-and organisational rethinking, including shorter work weeks or universal basic income in high-growth scenarios.^1,3,5

This reflects Mollick's four future scenarios from Co-Intelligence: 'As Good As It Gets' (plateau), 'Slow Growth' (manageable integration), 'Exponential Growth' (severe, unpredictable risks with AI self-improving), and 'The Machine God' (autonomous superintelligence). He urges focus on the path 'between here and some imagined future', prioritising today's agentic shifts and ethical guardrails over remote singularities.¹

Leading Theorists on AI Disruption and Risks

Mollick's views build on foundational thinkers who shaped AI risk discourse:

• Nick Bostrom (Oxford Future of Humanity Institute): In Superintelligence (2014), Bostrom warns of existential risks from misaligned superintelligent AI pursuing goals orthogonally to humanity's. His 'control problem'-ensuring AI obedience-influences Mollick's guardrail emphasis.¹
• Stuart Russell (UC Berkeley): Co-author of Artificial Intelligence: A Modern Approach, Russell advocates 'provably beneficial AI' via uncertainty about human preferences. His book Human Compatible (2019) stresses inverse reinforcement learning, aligning with Mollick's human-in-the-loop principle.¹
• Ray Kurzweil: Google's Director of Engineering predicts the Singularity by 2045-AI surpassing human intelligence via exponential growth. Kurzweil's law of accelerating returns informs Mollick's exponential scenarios, though Mollick tempers optimism with pragmatic disruption focus.¹
• Timnit Gebru and Margaret Mitchell: Pioneers in AI ethics, their work on bias and safety (e.g., Stochastic Parrots paper) underscores immediate risks like misinformation, echoing Mollick's calls for ethical AI interactions.⁴

These theorists highlight a spectrum: from alignment challenges (Bostrom, Russell) to accelerationism (Kurzweil) and equity concerns (Gebru). Mollick synthesises them into actionable advice, bridging theory and practice for leaders facing 2026's agentic wave.^1,2,3,4

Quote: Reid Wiseman - Artemis II Mission commander

"You get to that point where you do not have to communicate any longer - you're just listening to everything happening, and all four of us are watching each other and the mission, and we do not need to speak - we just know." - Reid Wiseman - Artemis II Mission commander

The challenge of maintaining flawless team coordination across vast distances defines deep space exploration. Light-speed delays render real-time communication impossible beyond low Earth orbit, forcing crews to operate autonomously for hours or days. Artemis II, NASA's first crewed lunar flyby since Apollo 17 in 1972, tests this limit as four astronauts hurtle 400,000 kilometres from Earth in the Orion spacecraft. Communication blackouts lasting up to 45 minutes demand implicit trust and non-verbal cues, elevating crew synergy to a survival imperative ¹.

Artemis II: Reviving Human Lunar Ambition Amid Technical and Fiscal Hurdles

Scheduled for no earlier than September 2026 after repeated delays from heat shield anomalies and valve failures, Artemis II marks humanity's return to cislunar space. NASA aims to circumnavigate the Moon without landing, validating Orion's life support, propulsion, and re-entry systems for future missions like Artemis III's south pole landing. The 10-day flight path traces an inverted '8' around the Moon, peaking at 100 km altitude, exposing the crew to unprecedented radiation and isolation. Budget overruns exceeding $4 billion underscore the programme's stakes, with Orion's development costs ballooning from $11 billion to over $20 billion since 2011 [2].

Orion's design prioritises deep space endurance: solar arrays generate 12 kW, lithium-ion batteries sustain power during eclipse, and the European Service Module provides 33 tonnes of propellant for mid-course corrections. Yet, the spacecraft's compact 11-cubic-metre crew cabin amplifies interpersonal dynamics, where a single miscommunication could cascade into catastrophe. Historical precedents like Apollo 13's oxygen tank rupture highlight how crew resourcefulness compensates for engineering flaws, but Artemis II's extended duration-twice Apollo's outbound leg-intensifies psychological pressures [3].

Reid Wiseman: From Test Pilot to Mission Commander in NASA's New Guard

Commander Reid Wiseman, a 48-year-old Navy test pilot with 180 days on the International Space Station from Expedition 41, embodies NASA's shift towards seasoned operators. Selected in 2009, Wiseman logged 50 Soyuz docking simulations and commanded the station's Node 1 during a 2014 spacewalk. His Artemis II role demands orchestrating a diverse crew: pilot Victor Glover, the first Black astronaut for a lunar mission; mission specialist Christina Koch, record-holder for the longest single spaceflight by a woman at 328 days; and CSA astronaut Jeremy Hansen, Canada's first moon-bound explorer. This quartet's chemistry, forged in years of analogue training at NASA's Johnson Space Center, underpins the mission's success ¹.

Wiseman's leadership draws from combat aviation, where split-second decisions hinge on unspoken rapport. Artemis training regimens-centrifuge runs simulating 9g re-entry, neutral buoyancy labs for suited manoeuvres, and hyperbaric chambers for decompression drills-instil muscle memory. Crews endure 2.5 years of integrated rehearsals, progressing from scripted procedures to free-play scenarios mimicking failures like thruster malfunctions or solar flare alerts. This culminates in wordless intuition, where eye contact conveys status checks faster than voice loops clogged with telemetry [4].

The Science of Non-Verbal Crew Cohesion Under Extreme Isolation

High-stakes teams achieve 'shared mental models' through neuroplastic adaptation, where repeated exposure syncs physiological states. Studies from Antarctic overwintering and submarine patrols reveal cortisol levels drop 30% in cohesive groups, enhancing threat detection via micro-expressions. NASA's Human Research Program quantifies this via EEG headsets during HI-SEAS Mars simulations, showing alpha wave synchrony predicts 85% of task efficiency. In Orion, biometric sensors monitor heart rate variability and galvanic skin response, feeding algorithms that flag desynchrony before verbal alerts [5].

Artemis II amplifies these dynamics: at lunar distance, a round-trip signal delay hits 2.5 seconds, but service module outages erase voice entirely. Crews revert to procedural hand signals refined in vacuum chambers, echoing Apollo's 'thumbs up' for hatch seals. Psychological screening via the Big Five personality inventory ensures complementarity-Wiseman's extraversion balances Koch's conscientiousness-fostering 'emergent communication' where gestures encode complex data like fuel margins or trajectory tweaks [6].

Strategic Tensions: Human Intuition Versus Autonomous Systems

NASA's pivot to commercial partners like SpaceX's Starship for Artemis III introduces hybrid crews blending pilots with engineers, straining traditional hierarchies. Starship's 100-passenger capacity envisions lunar bases, but Orion's four-person intimacy preserves Apollo-era bonding. Critics argue over-reliance on human oversight ignores AI advancements; SpaceX's autonomous docking boasts 99.9% reliability, yet Wiseman's crew retains veto authority, reflecting distrust in black-box algorithms during anomalies [7].

Geopolitical frictions compound this: China's Chang'e programme eyes south pole resources by 2030, prompting NASA's Artemis Accords-signed by 45 nations-to secure 'safe zones'. Crew cohesion becomes a soft-power asset, projecting American resilience. Delays from Boeing's SLS rocket-$23 billion and counting-fuel debates on privatisation, with Musk advocating full reusability to slash costs 90%. Artemis II's success hinges on proving human crews outperform drones in ambiguous crises, like Apollo 13's slingshot manoeuvre [8].

Debates and Objections: Is Implicit Trust Overhyped?

Sceptics question romanticising silence amid data overload. Orion generates 1.8 terabytes daily from 1,000 sensors, demanding verbal triage to avoid cognitive overload. Former astronaut Chris Hadfield warns non-verbal cues falter under fatigue, citing Skylab's interpersonal strife. Diversity advocates praise the crew's composition but flag implicit bias in training, where male-dominated simulations undervalue Koch's input. Radiation exposure-up to 1 sievert, 300 times annual limits-induces nausea, eroding rapport [9].

Counterarguments cite analogue missions: NASA's CHAPEA buried four volunteers in a 3D-printed Mars habitat for 378 days, achieving 92% procedural compliance via non-verbals. HI-SEAS crews logged zero mission aborts despite 20% depression rates. Objectors like planetary scientist Phil Plait argue AI copilots, trained on billions of simulations, exceed human bandwidth, but NASA counters with 'judgement calls'-e.g., Apollo 11's manual landing-unattainable by current neural nets [10].

Technological Backbone Enabling Silent Operations

Orion's glass cockpit fuses 10 touchscreen displays with heads-up projections, minimising head movements for peripheral awareness. Augmented reality visors overlay telemetry, allowing glance-based status reads. The crew's 'loop discipline'-prioritising brevity-frees bandwidth for observation, with auto-transcripts logging nuance. Post-mission debriefs dissect these moments, refining selection for Artemis III's 30-day loiter [11].

Why This Capability Matters for Lunar Settlement and Beyond

Wordless synergy scales to multi-crew outposts, where bandwidth rationing mandates efficiency. Artemis paves for Gateway station, orbiting Lagrange points with six-person rotations. Implicit trust mitigates 'Earth-out-of-view' syndrome, slashing 40% of behavioural risks per NASA models. Economically, it justifies $93 billion Artemis investment by enabling ISRU-lunar water mining for propellant-staffed by intuitive teams [12].

Militarily, it informs crewed cislunar patrols amid rising orbital congestion (36,000 satellites by 2030). Philosophically, it reaffirms human agency in an AI-saturated era, where machines execute but crews improvise. As Artemis II hurtles towards its uncrewed dress rehearsal in 2025, Wiseman's insight spotlights the irreplaceable human core: not just surviving space, but thriving through unspoken bonds ¹.

References

1. BBC News. Artemis II: Inside the Moon mission to fly humans further than ever. bbc.co.uk
2. NASA Office of Inspector General. 2024 Orion Audit Report.
3. Lovell, J. Lost Moon. Houghton Mifflin, 1994.
4. NASA Johnson Space Center Training Overview.
5. Human Research Program: Synchrony Studies, 2023.
6. Big Five Inventory in Astronaut Selection, Acta Astronautica, 2022.
7. SpaceX Starship Updates, 2025.
8. Artemis Accords Signatories, State Department, 2025.
9. Hadfield, C. An Astronaut's Guide. Knopf, 2013.
10. CHAPEA Mission Report, NASA, 2025.
11. Orion Avionics Specifications, Lockheed Martin.
12. Gateway Programme Baseline, 2026.

Quote: Jensen Huang - Nvidia CEO

"I'll take every possible opportunity, external information, new insights, new discoveries, new engineering ... I'll take those opportunities and I'll use it to shape everybody else's belief system. And I'm doing that literally every single day." - Jensen Huang - Nvidia CEO

Jensen Huang, co-founder and CEO of NVIDIA, shared insights on his leadership approach during Lex Fridman Podcast #494 (March 23, 2026), emphasizing how he leverages continuous learning to shape organizational beliefs.

This statement reflects Huang's strategic approach to leadership at NVIDIA, the world's most valuable company and primary engine powering the AI computing revolution. According to the podcast discussion, Huang emphasizes the importance of shaping the beliefs of employees, partners, and the broader industry through continuous engagement with emerging innovations and discoveries.

The quote underscores a deliberate leadership philosophy where Huang actively translates external developments-whether technological breakthroughs, market insights, or engineering advances-into organizational culture and strategic direction. This approach aligns with NVIDIA's evolution into what Huang describes as an "AI factory," requiring extreme co-design across GPU, CPU, memory, networking, and software systems.

Huang's emphasis on daily belief-shaping reflects his broader vision for anticipating future AI innovations, including agentic systems and open-source models, while maintaining organizational alignment around these forward-looking priorities.

Term: Limited partner (LP)

"A limited partner (LP) is an investor in a private equity fund who provides capital but does not participate in the day-to-day management of the fund." - Limited partner (LP)

A limited partner (LP) is a passive investor who contributes capital to a private equity or venture capital fund in exchange for a proportionate share of profits, whilst maintaining limited liability and no involvement in day-to-day management or operational decisions.^1,2

Core Characteristics and Structure

Limited partners are distinguished by several defining features that shape their role within private equity funds. Their liability is capped at the amount of capital they invest, meaning they cannot lose more than their initial contribution regardless of the fund's performance or debts incurred.^1,2 This liability protection is a primary attraction for institutional and individual investors seeking to diversify their portfolios whilst managing risk exposure.

The relationship between LPs and the fund is governed by a limited partnership agreement (LPA), a legally binding contract that specifies ownership percentages, profit distribution mechanisms, management fee structures, and the decision-making authority of general partners (GPs).^1,3 Whilst LPs remain passive in operational matters, they retain certain rights, including the ability to approve major changes to the business plan or structure (typically by majority vote) and to review financial statements and request updates on fund performance.¹

Types of Limited Partners

Limited partners in private equity encompass three primary categories:^1,4

• Institutional LPs include pension funds, endowments, foundations, and sovereign wealth funds-organisations with substantial capital reserves and mandates to generate consistent returns over extended timelines.¹
• Individual LPs are typically high-net-worth individuals who invest personal capital into private funds or directly into startups as angel investors.¹
• Family offices are private firms managing the finances of wealthy families, often making both fund investments and direct startup investments.¹

Limited Partners versus General Partners

The distinction between LPs and GPs is fundamental to private equity fund structure. Whilst limited partners provide the financial capital that fuels fund operations, general partners assume active management responsibility, making investment decisions, sourcing portfolio companies, and overseeing fund operations.^1,6 GPs carry unlimited liability and receive compensation through management fees and carried interest (a percentage of profits), aligning their interests with fund performance.^1,6

Limited partners, conversely, are sometimes referred to as "silent partners" or "passive investors" because of their hands-off operational role.^1,6 They entrust strategic decision-making entirely to GPs whilst maintaining their right to monitor fund progress and approve significant structural changes.¹

Investment Process and Capital Deployment

Limited partners commit to providing a specified amount of capital during the fund's lifetime, though capital is typically deployed in tranches as investment opportunities arise.⁶ GPs request capital from LPs when they identify suitable acquisition targets or investment opportunities.⁶ This staged capital deployment allows LPs to maintain liquidity whilst ensuring their committed capital is deployed strategically rather than immediately upon fund formation.

In return for their capital contribution, LPs receive distributions of profits according to the terms outlined in the LPA, typically after GPs recover their management fees and realise their carried interest.^1,3

Key Advantages and Constraints

The LP structure offers significant advantages: investors gain access to high-growth private investments, benefit from professional fund management, and achieve portfolio diversification across multiple ventures whilst limiting personal financial risk.² However, limited partners also face notable constraints, including illiquidity (capital is typically locked in for 7-10 years), limited control over investment decisions, and exposure to underperforming funds or adverse regulatory changes.³

Historical Context and Theoretical Framework

William D. Bygrave, a pioneering venture capital theorist and professor at Babson College, significantly shaped contemporary understanding of LP-GP relationships and fund structures. Bygrave's foundational work in the 1980s and 1990s established the theoretical framework for analysing how limited partners and general partners interact within venture capital ecosystems. His research emphasised the agency problem inherent in the LP-GP relationship-the tension between passive investors seeking returns and active managers pursuing their own interests.

Bygrave's contributions extended beyond theory into practical fund governance. He developed models demonstrating how limited partnership agreements could be structured to align GP incentives with LP interests, addressing information asymmetries and moral hazard concerns. His work at Babson College, where he founded the Center for Entrepreneurial Studies, trained generations of venture capitalists and institutional investors in understanding optimal fund structures. Bygrave's research highlighted that successful private equity and venture capital funds depend critically on clear contractual frameworks-precisely the LPAs that govern modern LP-GP relationships.

His emphasis on the importance of transparent communication, aligned incentives, and well-drafted partnership agreements remains foundational to contemporary private equity practice. Bygrave's theoretical insights into how limited partners can effectively monitor general partners without micromanaging operations continue to influence institutional investor policies and fund governance standards across the private capital industry.

Regulatory and Qualification Requirements

To participate as a limited partner in private equity funds, investors must meet specific legal definitions of qualified investors, a classification that typically includes public pension funds, endowments, insurance companies, and high-net-worth individuals meeting minimum asset thresholds.⁵ These requirements exist to ensure that LP investors possess sufficient financial sophistication and resources to understand the risks associated with illiquid, long-term private capital investments.

Quote: George Bernard Shaw - Nobel-winning playwright

"The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself." - George Bernard Shaw - Nobel-winning playwright

This iconic observation by George Bernard Shaw encapsulates his lifelong commitment to challenging societal norms and advocating for bold reform. Shaw, an Irish-born playwright, critic, and socialist, used his wit and satire to dissect class structures, morality, and human behaviour, urging society to confront uncomfortable truths rather than passively accept the status quo^1,2,3.

George Bernard Shaw: A Life of Literary and Social Defiance

Born on 26 July 1856 in Dublin, Ireland, George Bernard Shaw grew up in a Protestant middle-class family marked by financial struggles and domestic discord. His father's alcoholism and his mother's elopement with a music teacher profoundly shaped his views on marriage, class, and convention. At 20, Shaw moved to London in 1876, where he initially struggled as a novelist and journalist before finding his calling in drama^2,3.

Shaw's breakthrough came in the 1890s, influenced by Norwegian playwright Henrik Ibsen, whose realism inspired Shaw to infuse English theatre with social critique. His early collections, Plays Unpleasant (1898) and Plays Pleasant (1898), tackled exploitation, hypocrisy, and idealism. Hits like Arms and the Man (1894), Candida (1894), and Man and Superman (1903) blended comedy with Fabian socialism-a gradualist approach to reform that Shaw championed as a co-founder of the Fabian Society and the London School of Economics^1,2,4.

His masterpiece Pygmalion (1913), a sharp commentary on class and language, propelled him to global fame, later adapted into the musical My Fair Lady. Shaw penned over 60 plays, including Major Barbara (1905), The Doctor's Dilemma (1906), Caesar and Cleopatra (1898), Androcles and the Lion (1912), and Saint Joan (1923). In 1925, he received the Nobel Prize in Literature for work 'marked by both idealism and humanity, its stimulating satire often being infused with a singular poetic beauty'^1,2,6. Remarkably, he became the first person to win both a Nobel and an Oscar, the latter in 1939 for the Pygmalion screenplay-though he scorned the award as an 'insult' from Hollywood^1,5.

Shaw declined numerous honours, including a knighthood and a parliamentary seat, and donated his Nobel prize money to translate August Strindberg's works. A vegetarian, spelling reformer, and eugenics advocate (controversial by modern standards), he lived to 94, dying on 2 November 1950 in Hertfordshire, England^1,2,3.

The Quote's Origins and Context

Shaw's maxim appears in the preface to his 1903 play Man and Superman, a philosophical comedy exploring human evolution, will, and the 'Life Force'-Shaw's concept of creative energy driving progress. It contrasts the 'reasonable' conformist with the 'unreasonable' innovator who reshapes reality. Shaw elaborated: 'Therefore, all progress depends on the unreasonable man,' positioning unreasonableness as essential for advancement².

In the Edwardian era of rigid hierarchies, Shaw used this to champion socialism, women's rights, and anti-war sentiments. Written amid his rising fame, it reflects his Fabian belief in persistent, intellectual agitation over passive adaptation-a theme echoed in plays like Major Barbara, where moral compromise clashes with principled action^1,2.

Leading Theorists on Reason, Adaptation, and Progress

Shaw's idea draws from and influences key thinkers on human agency and societal change:

• Henrik Ibsen (1828-1906): Shaw's primary influence, Ibsen's realist dramas like A Doll's House (1879) challenged norms, portraying individuals adapting-or rebelling against-society's constraints, much like Shaw's unreasonable reformer².
• Friedrich Nietzsche (1844-1900): The philosopher's Thus Spoke Zarathustra (1883-1885) celebrates the 'overman' who transcends conventional morality, paralleling Shaw's praise for those who impose their will on the world².
• Karl Marx (1818-1883) and Fabian Socialists: Shaw, a Fabian, adapted Marx's class struggle into gradual reform. Thinkers like Sidney Webb (co-founder of the Fabian Society) advocated persistent intellectual pressure to evolve society, embodying the 'unreasonable' persistence^1,4.
• 20th-Century Echoes: George Orwell cited Shaw's quote approvingly, while modern innovators like Steve Jobs echoed it: 'The people who are crazy enough to think they can change the world are the ones who do.' It underpins theories in psychology (e.g., cognitive dissonance) and innovation studies, where disruptors defy norms².

Shaw's words remain a rallying cry for leaders, entrepreneurs, and reformers, reminding us that true progress demands the courage to be unreasonable.

Term: Carried interest (carry)

"Carry, short for carried interest, is the share of a fund's investment profits allocated to the general partner (GP) as performance compensation." - Carried interest (carry)

Carried interest, commonly abbreviated as "carry," represents a share of the profits earned from a fund's investments that is allocated to the general partner (GP) as performance compensation^1,6. This mechanism is fundamental to the structure of alternative investment funds, including private equity, venture capital, and hedge funds, serving as a primary incentive tool to align the interests of fund managers with those of their investors.

Core Structure and Function

In a typical private investment fund structure, a general partner (GP) raises capital from limited partners (LPs), who provide the investment capital⁴. The GP manages the fund, makes investment decisions, and oversees the portfolio companies. Rather than being compensated solely through management fees, the GP receives carried interest as a performance-based reward¹. This arrangement ensures that the GP has "skin in the game"-a direct financial stake in maximising returns for all investors¹.

Carried interest is only paid once the fund has returned investors' capital and surpassed a minimum hurdle rate of return, which is typically between 8% and 10%^1,3. This structure protects limited partners by ensuring that managers do not profit until investors have achieved their target returns. The specific terms governing carried interest allocation, including the hurdle rate and distribution waterfall (the order in which proceeds are distributed), are detailed in the fund's investment agreement¹.

Calculation and Typical Allocations

Carried interest is calculated as a percentage of the fund's total profits above the hurdle rate. The formula is straightforward:

Carried Interest = Total Fund Profits × Performance Fee Percentage

For example, if a fund invests £100 million, achieves a final value of £140 million (exceeding an 8% hurdle rate), and the GP receives 20% of profits, the carried interest would be calculated as follows¹:

• Total fund profits = £140 million ? £100 million = £40 million
• Carried interest = £40 million × 20% = £8 million
• Remaining profits to LPs = £32 million

In private equity, the standard carried interest allocation is typically 20% of profits to the GP and 80% to the LPs². However, this varies depending on fund type, market conditions, and investor demand. Some prominent firms, such as Bain Capital and Providence Equity Partners, command "super carry" arrangements exceeding 20%⁶. Venture capital and hedge funds may have different structures, with venture capital funds often following similar 20% allocations⁸.

Relationship to Compensation and Wealth Generation

Carried interest serves as a primary source of long-term wealth generation for fund managers, distinct from their annual management fees (typically 2% of assets under management)⁴. The performance fee structure creates powerful incentives for GPs to identify high-quality investment opportunities, actively manage portfolio companies, and execute profitable exits. This alignment of interests is widely accepted by fund investors as assurance that GP objectives match their own¹.

In real estate development, carried interest is also known as a "promoted interest" or "promote." It compensates the developer (GP) for substantial risks undertaken during development and the period prior to property sale, whilst aligning the developer's interests with those of equity investors⁷.

Tax Treatment

Carried interest has traditionally received favourable tax treatment. In the United States, it is typically taxed as long-term capital gains rather than ordinary income, provided the fund holds assets for more than three years². This preferential treatment has made carried interest a subject of ongoing tax policy debate, with critics referring to it as the "carried interest loophole" or "Wall Street's favourite tax break"⁶. The Tax Cuts and Jobs Act of 2017 extended the holding period requirement from one year to more than three years for long-term capital gains treatment, though most private equity funds hold assets for five years or longer, limiting the practical impact of this change².

Key Theorist: Jensen and Meckling on Agency Alignment

Michael C. Jensen and William H. Meckling provided foundational theoretical work on the agency problem and incentive alignment that underpins the carried interest model. Their seminal 1976 paper, "Theory of the Firm: Managerial Behaviour, Agency Costs and Ownership Structure," established the conceptual framework for understanding how performance-based compensation structures can mitigate conflicts between managers and investors.

Michael Jensen (1939-2019) was the Harvard Business School professor and leading organisational economist who spent much of his career examining how compensation structures influence managerial behaviour. Born in Rochester, New York, Jensen earned his PhD in economics from the University of Chicago and became renowned for his rigorous empirical and theoretical work on corporate governance. His research demonstrated that when managers have a direct financial stake in firm performance-what he termed "skin in the game"-they are incentivised to make decisions that maximise shareholder value rather than pursuing self-interested objectives¹.

Jensen's work was particularly influential in legitimising the private equity model during the 1980s and 1990s. He argued that the combination of management fees (to cover operational costs) and carried interest (to reward performance) created an optimal incentive structure. This framework became the intellectual foundation for the explosive growth of private equity and venture capital industries. Jensen's research on leveraged buyouts and the role of debt in disciplining management further supported the theoretical case for carried interest as a mechanism to align interests in alternative investment structures.

William H. Meckling (1927-1998) was Jensen's collaborator and a professor at the University of Rochester. Together, they developed agency theory-the economic framework explaining how principals (investors) can structure contracts with agents (managers) to minimise agency costs. Their work demonstrated mathematically that performance-based compensation reduces the divergence between managerial and investor interests. Meckling's contributions emphasised the importance of monitoring and incentive alignment, principles that directly informed the design of carried interest arrangements in modern investment funds.

The Jensen-Meckling framework remains the dominant theoretical justification for carried interest. Their insight that managers with equity-like stakes in performance outcomes will behave differently than salaried employees has proven remarkably durable, shaping not only private equity and venture capital but also executive compensation practices across corporate America. Their work established that carried interest is not merely a compensation mechanism but a structural solution to a fundamental economic problem: ensuring that those making investment decisions bear the consequences of their choices.